Cambrex Presentation at The JPMorgan Healthcare Conference to be Webcast

EAST RUTHERFORD, N.J., Jan. 5 Cambrex Corporation (NYSE: CBM) is pleased to announce that Steven M. Klosk, President and Chief Executive Officer, will be presenting at the JPMorgan Healthcare Conference on January 13, 2009 at 9:00 a.m. PST at the Westin St. Francis, San Francisco, California.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO )

A live webcast of the presentation will be accessible during the conference from http://metameetings.com/webcasts/jpmorgan/healthcare09/directlink?ticker=CBM. An archive of the presentation will be available for approximately 90 days after the conference.

The webcast and the slide presentation can also be accessed from the Cambrex website www.cambrex.com in the Webcasts section of the Investor Relations page.

About Cambrex

Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including active pharmaceutical ingredients ("APIs"), advanced intermediates, enhanced drug delivery and other products for branded and generic pharmaceuticals. The Company currently employs approximately 850 people worldwide. For more information, please visit http://www.cambrex.com.

SOURCE Cambrex Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...